OCT 10, 2019 7:30 AM PDT

Keynote Presentation: Cancer Prevention for the Practicing Oncologist - Recommendations for Cancer Patients and Their Families

C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Vice President & Division Head for Cancer Prevention & Population Sciences, University of Texas MD Anderson Cancer Center
    Biography
      Ernest Hawk, MD, MPH, is vice president and division head for Cancer Prevention and Population Sciences at The University of Texas MD Anderson Cancer Center and holds the Boone Pickens Distinguished Chair for Early Prevention of Cancer. Additional responsibilities include leadership of the Duncan Family Institute for Cancer Prevention and Risk Assessment which fuels critical prevention research initiatives and infrastructures of the center, as well as service as co-leader of MD Anderson's Cancer Prevention and Control Platform. The Platform plans, implements, and evaluates evidence-based actions in public policy, professional/public education, and community-based service delivery to reduce cancer and related risk factors at the population level. His personal research interests over the last two decades include preclinical and clinical drug development for cancer prevention, the conduct of a variety of clinical trials in cancer prevention, and the inclusion of diverse and underserved populations in cancer clinical trials, clinical research, and cancer control programs to improve outcomes and promote equity. He earned his medical degree from Wayne State University and his MPH degree from Johns Hopkins University. Additionally, he received training in internal medicine and served as a staff physician at Emory University, completed a medical oncology fellowship at the University of California, San Francisco, and completed a cancer prevention fellowship at the National Cancer Institute.

    Abstract:

    The Keynote Address will highlight eight actions that individuals can take to reduce their cancer risk. These recommendations span lifestyle modifications, cancer screening and molecular prevention. The evidence supporting these recommendations will be reviewed. The presentation will also describe the elements of a clinical cancer prevention program, using examples from MD Anderson’s Cancer Prevention Center.

    Learning Objectives:

    1. Identify evidence-based actions that can be recommended to individuals to reduce their cancer risk and understand the data supporting them.
    2. Describe elements of building a clinical cancer prevention program.


    Show Resources
    You May Also Like
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    NOV 18, 2019 7:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 7:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    FEB 25, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    MAR 03, 2020 9:00 AM JST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    DEC 10, 2019 9:00 AM PST
    C.E. CREDITS
    DEC 10, 2019 9:00 AM PST
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    Loading Comments...
    Show Resources
    Attendees